Carregant...
Induction Immunosuppressive Therapy in the Elderly Kidney Transplant Recipient in the United States
SUMMARY: BACKGROUND AND OBJECTIVES: The choice of induction agent in the elderly kidney transplant recipient is unclear. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The risks of rejection at 1 year, functional graft loss, and death by induction agent (IL2 receptor antibodies [IL2RA], alemtuzu...
Guardat en:
| Autors principals: | , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society of Nephrology
2011
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3087785/ https://ncbi.nlm.nih.gov/pubmed/21511836 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.07540810 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|